Classical monoamine oxidase inhibitors: Not registered for, but still a place in the treatment of depression;Klassieke monoamineoxidaseremmers: Niet geregistreerd, maar wel een plaats in de behandeling van depressies

Nederlands Tijdschrift voor Geneeskunde

Volumn 147, Issue 40, 2003, Pages 1940-1943

  Nolen, W A ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; MONOAMINE OXIDASE INHIBITOR; PHENELZINE; SEROTONIN UPTAKE INHIBITOR; TRANYLCYPROMINE; TYRAMINE;

DEPRESSION; DRUG APPROVAL; FOOD; FOOD DRUG INTERACTION; HEADACHE; HUMAN; HYPERTENSION; HYPOTENSION; LONG TERM CARE; NETHERLANDS; NEUROMUSCULAR DISEASE; RELAPSE; REVIEW; SLEEP DISORDER; TREATMENT INDICATION;

DEPRESSIVE DISORDER; DRUG INTERACTIONS; FOOD-DRUG INTERACTIONS; HUMANS; MONOAMINE OXIDASE INHIBITORS; NETHERLANDS; PHENELZINE; RECURRENCE; TIME FACTORS; TRANYLCYPROMINE;

EID: 0141671763     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (14)

1. Medical Research Council. Clinical trial of the treatment of depressive illness. Clinical Psychiatry Committee. Br Med J 1965;i:881-6.
2. Thase ME, Trivedi MH, Rush AJ. MAOIs in the contemporary treatment of depression. Neuropsychopharmacology 1995;12:185-219.
3. Quitkin FM, Stewart JW, McGrath PJ, Tricamo E, Rabkin JG, Ocepek-Welikson K, et al. Columbia atypical depression. A sub-group of depressives with better response to MAOI than to tricyclic antidepressants or placebo. Br J Psychiatry Suppl 1993;21: 30-4.
4. Himmelhoch JM, Thase ME. Mallinger AG, Houck P. Tranylcypromine versus imipramine in anergic bipolar depression. Am J Psychiatry 1991;148:910-6.
5. Nolen WA, Putte JJ van de, Dijken WA, Kamp JS, Blansjaar BA, Kramer HJ, et al. Treatment strategy in depression. II. MAO inhibitors in depression resistant to cyclic antidepressants: two controlled crossover studies with tranylcypromine versus L-5-hydroxytryptophan and nomifensine. Acta Psychiatr Scand 1988;78:676-83.
6. Murphy DL, Garrick NA, Aulakh CS, Cohen RM. New contributions from basic science to understanding the effects of monoamine oxidase inhibiting antidepressants. J Clin Psychiatry 1984;45(7 Pt 2):37-43.
7. Meiracker AH van den, Dees A. Hypertensieve crisis: definitie, pathofysiologie en behandeling. Ned Tijdschr Geneeskd 1999;143:2185-90.
8. Lathers CM, Charles JB. Orthostatic hypotension in patients, bed rest subjects, and astronauts. J Clin Pharmacol 1994;34:403-17.
9. Jacobsen FM. Low-dose trazodone as a hypnotic in patients treated with MAOIs and other psychotropics: a pilot study. J Clin Psychiatry 1990;51:298-302.
10. Vink J, Nolen WA, Verbraak M. Is moclobemide bij therapie-resistente depressie een alternatief voor tranylcypromine? Enige ervaringen. Tijdschrift voor Psychiatrie 1994;36:639-46.
11. Mann JJ, Aarons SF, Wilner PJ, Keilp JG, Sweeney JA, Pearlstein T, et al. A controlled study of the antidepressant efficacy and side effects of (-)-deprenyl. A selective monoamine oxidase inhibitor. Arch Gen Psychiatry 1989:46:45-50
12. Groot PA de. Consensus depressie bij volwassenen. Ned Tijdschr Geneeskd 1995;39:1237-41.
13. Nolen WA, Knoppert-van der Klein EAM, Honig A, Bouvy PF, Klompenhouwer JL, Witt A de, et al. Richtlijn bipolaire stoornissen. Nederlandse Vereniging voor Psychiatrie. Amsterdam: Boom; 2001.
14. Oostervink F. Bouvy PF, Touw DJ. Ouderen, klassieke monoamine-oxidaseremmers en intercurrente somatische aandoeningen Ned Tijdschr Geneeskd 2003;147:1937-40.